tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126

Compare JW (Cayman) Therapeutics Co. Ltd. (2126) vs. Competitors

1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
JW (Cayman) Therapeutics Co. Ltd.
HK$2.50
HK$949.56M
-1.73
58.33%
Alphamab Oncology
HK$9.39
HK$9.15B
-76.25
58.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$10.74B
30.77
58.83%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.35B
-3.21
-29.19%
CStone Pharmaceuticals
HK$5.34
HK$14.64B
-15.44
335.93%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.15
HK$4.45B
558.59
-12.59%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.28
0.76
50.00%
HK:9966
Alphamab Oncology
9.39
2.74
41.20%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.78
1.61
38.61%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
4.90
-2.02
-29.19%
HK:2616
CStone Pharmaceuticals
10.07
7.40
277.15%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.15
-1.13
-13.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts